493 related articles for article (PubMed ID: 12784269)
1. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U
Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
[TBL] [Abstract][Full Text] [Related]
2. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Razmy A; Lang AE; Shapiro CM
Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
[TBL] [Abstract][Full Text] [Related]
3. Sleepiness in Parkinson's disease: a controlled study.
Brodsky MA; Godbold J; Roth T; Olanow CW
Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
[TBL] [Abstract][Full Text] [Related]
4. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
Romigi A; Brusa L; Marciani MG; Pierantozzi M; Placidi F; Izzi F; Sperli F; Testa F; Stanzione P
J Neurol Sci; 2005 Jan; 228(1):7-10. PubMed ID: 15607203
[TBL] [Abstract][Full Text] [Related]
5. Excessive daytime sleepiness in parkinsonism.
Arnulf I
Sleep Med Rev; 2005 Jun; 9(3):185-200. PubMed ID: 15893249
[TBL] [Abstract][Full Text] [Related]
6. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease.
Suzuki K; Miyamoto T; Miyamoto M; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
J Neurol Sci; 2008 Aug; 271(1-2):47-52. PubMed ID: 18436241
[TBL] [Abstract][Full Text] [Related]
7. Dopamine agonists and sleepiness in PD: review of the literature and personal findings.
Manni R; Terzaghi M; Sartori I; Mancini F; Pacchetti C
Sleep Med; 2004 Mar; 5(2):189-93. PubMed ID: 15033142
[TBL] [Abstract][Full Text] [Related]
8. Sudden uncontrollable somnolence and medication use in Parkinson disease.
Avorn J; Schneeweiss S; Sudarsky LR; Benner J; Kiyota Y; Levin R; Glynn RJ
Arch Neurol; 2005 Aug; 62(8):1242-8. PubMed ID: 16087765
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
Möller JC; Stiasny K; Hargutt V; Cassel W; Tietze H; Peter JH; Krüger HP; Oertel WH
Mov Disord; 2002 May; 17(3):474-81. PubMed ID: 12112193
[TBL] [Abstract][Full Text] [Related]
10. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?
Chaudhuri KR; Pal S; Brefel-Courbon C
Drug Saf; 2002; 25(7):473-83. PubMed ID: 12093305
[TBL] [Abstract][Full Text] [Related]
11. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
12. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
Del Dotto P; Gambaccini G; Caneparo D; Berti C; Bernardini S; Bonuccelli U
Neurol Sci; 2003 Oct; 24(3):170-1. PubMed ID: 14598071
[TBL] [Abstract][Full Text] [Related]
13. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.
Hobson DE; Lang AE; Martin WR; Razmy A; Rivest J; Fleming J
JAMA; 2002 Jan 23-30; 287(4):455-63. PubMed ID: 11798367
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
15. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
Pal S; Bhattacharya KF; Agapito C; Chaudhuri KR
J Neural Transm (Vienna); 2001; 108(1):71-7. PubMed ID: 11261748
[TBL] [Abstract][Full Text] [Related]
16. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.
Dusek P; Busková J; Růzicka E; Majerová V; Srp A; Jech R; Roth J; Sonka K
Clin Neuropharmacol; 2010 Jul; 33(4):186-90. PubMed ID: 20661025
[TBL] [Abstract][Full Text] [Related]
17. Predictors of sudden onset of sleep in Parkinson's disease.
Körner Y; Meindorfner C; Möller JC; Stiasny-Kolster K; Haja D; Cassel W; Oertel WH; Krüger HP
Mov Disord; 2004 Nov; 19(11):1298-305. PubMed ID: 15389999
[TBL] [Abstract][Full Text] [Related]
18. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
Gjerstad MD; Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
Neurology; 2006 Sep; 67(5):853-8. PubMed ID: 16966550
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonists induce episodes of irresistible daytime sleepiness.
Schlesinger I; Ravin PD
Eur Neurol; 2003; 49(1):30-3. PubMed ID: 12464715
[TBL] [Abstract][Full Text] [Related]
20. Excessive daytime sleepiness in de novo and treated Parkinson's disease.
Fabbrini G; Barbanti P; Aurilia C; Vanacore N; Pauletti C; Meco G
Mov Disord; 2002 Sep; 17(5):1026-30. PubMed ID: 12360553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
